Australia markets open in 4 hours 25 minutes

NanoVibronix, Inc. (NAOV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7114-0.0374 (-4.99%)
As of 03:26PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.7488
Open0.7500
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.7100 - 0.7500
52-week range0.6780 - 4.3400
Volume16,508
Avg. volume43,693
Market cap1.994M
Beta (5Y monthly)1.30
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

    TYLER, Texas, May 14, 2024--NanoVibronix, Inc. (Nasdaq: NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC ("CB Medical") for the sale and distribution of the Company’s UroShield.

  • Business Wire

    NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award

    ELMSFORD, N.Y., May 01, 2024--NanoVibronix, Inc. (Nasdaq: NAOV) ("NanoVibronix," or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective May 1, 2024, the Company’s PainShield product will be included in the U.S. Department of Veteran Affairs’ ("VA") Federal Supply Schedule ("FSS"), a program that supports the healthcare acquisition needs of the VA and

  • Business Wire

    NanoVibronix Issues Letter to Stockholders

    ELMSFORD, N.Y., April 09, 2024--NanoVibronix, Inc., (NASDAQ: NAOV)("NanoVibronix"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to stockholders from its Chief Executive Officer, Brian Murphy, providing a review of the fourth quarter and full year 2023 and recent business developments.